CareDx CDNA 深 沪
等待开盘 09-30 09:30:00 美东时间
64.02
-0.580
-0.90%
华盛通- 最 高65.50
- 今 开64.74
- 成交量 79.63万股
- 最 低 62.895
- 昨 收 64.60
- 总市值 33.12亿
- 52周最高 65.50
- 市盈率 静 --
- 换手率 1.54%
- 52周最低 14.03
- 委 比 -41.86%
- 总股本 5173.42万
- 历史最高 99.83
- 量 比 0.41
- 振 幅 4.03%
- 历史最低 0.76
- 每 手 1
- 风险率 12.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股 | Grail升逾15%，Galleri癌症筛查工具获FDA专家组支持；Everpure升逾11%，2028财年业绩预测超分析师预期
Grail升逾15%，Galleri癌症筛查工具获FDA专家组支持；Everpure升逾11%，2028财年业绩预测超分析师预期>>
09-25 19:00
美股大行评级 | Meta获4家机构齐升目标价，最高看至995美元！麦当劳遭6家机构下调，最低看至260美元
今日重点评级关注：Canaccord Genuity：维持Aurora Innovation"买入"评级，目标价从15美元升至17美元；摩根大通：维持皇家加勒比邮轮"超配"评级，目标价从345美元升至394美元
09-25 15:55
BTIG Maintains Buy on CareDx, Raises Price Target to $74
BTIG analyst Mark Massaro maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $60 to $74.
09-24 18:11
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently
The Centers for Medicare & Medicaid Services plans to align its 2027 clinical laboratory fee schedule rates with private sector payer rates, aiming to curb excessive Medicare payments and save taxpayers an estimated $1 billion annually. • BillionToOne stock is facing resistance. What’s pulling BLLN ...
09-24 02:09
美股大行评级 | 最高735美元！戴尔科技绩后获11家大行上调目标价；MongoDB绩后分歧大，9家上调；4家下调；派拓网络、GitLab、美敦力获多家大行上调目标价
今日重点评级关注：Tigress Financial：维持Liftoff Mobile"买入"评级，目标价从39美元升至41美元；奥本海默：维持SpaceX"跑赢大市"评级，目标价从250美元升至280美元
09-03 13:50
Canaccord Genuity Initiates Coverage On CareDx with Buy Rating, Announces Price Target of $65
Canaccord Genuity analyst Kyle Mikson initiates coverage on CareDx (NASDAQ:CDNA) with a Buy rating and announces Price Target of $65.
09-02 23:40
High-flyer healthcare stocks: Ten names with strong momentum, weak valuations
Wall Street investors are increasingly seeking refuge in high-performing equity plays as volatile healthcare markets continue to shift, forcing a critical evaluation of stock price velocity against fu...
08-10 20:49
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
BTIG Maintains Buy on CareDx, Raises Price Target to $60
BTIG analyst Mark Massaro maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $45 to $60.
08-06 17:12
美股大行评级 | 最高400美元！亚马逊绩后获11家大行上调目标价；苹果绩后评级分歧大！3家上调，3家下调；德康医疗、万事达、神经分泌生物科学获多家大行上调目标价
今日重点评级关注：TD Cowen：维持加拿大鹅"买入"评级，目标价从13美元升至18美元；瑞银：维持吉登运动服"买入"评级，目标价从110美元升至111美元
08-03 11:38
